The market is divided into lots as follows:

- lot 1: “gonadorelin antagonists”;

- lot 2: "gonadorelin agonists";

- lot 3: "chorionic gonadotropins";

- lot 4: "urinary gonadotropins with FSH: LH activity having a 1: 1 ratio";

- lot 5: “short-acting recombinant gonadotropins, follitropin alpha or beta alone, in adult women”;

- lot 6: “short-acting recombinant gonadotropins with the indication“ stimulation of spermatogenesis in men with hypogonadotrophic hypogonadism ”reimbursed in Belgium”.

Provision of "gonadorelin antagonists".

Supply of "gonadorelin agonists".

Supply of "chorionic gonadotropins".

Provision of "urinary gonadotropins with FSH: LH activity having a 1: 1 ratio".

Provision of "short-acting recombinant gonadotropins, follitropin alpha or beta alone, in adult women".

Supply of “Short-acting recombinant gonadotrophins with the indication“ stimulation of spermatogenesis in men with hypogonadotrophic hypogonadism ”reimbursed in Belgium”.